Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
310
-
Total 13F shares, excl. options
-
41.9M
-
Shares change
-
-753K
-
Total reported value, excl. options
-
$3.27B
-
Value change
-
-$121M
-
Put/Call ratio
-
1.23
-
Number of buys
-
144
-
Number of sells
-
-230
-
Price
-
$78.06
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2019
435 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2019.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 310 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.9M shares
of 44.8M outstanding shares and own 93.59% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.49M shares), VANGUARD GROUP INC (3.99M shares), RENAISSANCE TECHNOLOGIES LLC (3.04M shares), FMR LLC (2.48M shares), STATE STREET CORP (1.84M shares), MILLENNIUM MANAGEMENT LLC (1.66M shares), Palo Alto Investors LP (1.55M shares), FIRST TRUST ADVISORS LP (1.21M shares), AQR CAPITAL MANAGEMENT LLC (1.13M shares), and ACADIAN ASSET MANAGEMENT LLC (913K shares).
This table shows the top 310 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.